Abstract
Our data underline the efficacy of active adjuvant treatment for GBM in overall survival, optimally with RTCT with Stupp protocol, even in an elderly and ECOG> 1 group, without grade III-IV toxicities. As expected, baseline ECOG (before starting local treatment), age and multifocal tumor are the most important prognosis predictor.
Original language | English |
---|---|
Pages (from-to) | S858-S860 |
Journal | Radiotherapy and Oncology |
Volume | 161 |
Issue number | Supplement 1 |
DOIs | |
Publication status | Published - 01 Aug 2021 |